These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Furukawa T; Fujisaki R; Yoshida Y; Kanai N; Sunamura M; Abe T; Takeda K; Matsuno S; Horii A Mod Pathol; 2005 Aug; 18(8):1034-42. PubMed ID: 15832194 [TBL] [Abstract][Full Text] [Related]
8. Morules in intraductal papillary mucinous neoplasm with an associated invasive carcinoma of the pancreas. Tateno Y; Esaki M; Shimada K; Ojima H; Kanai Y; Hiraoka N Pancreas; 2012 May; 41(4):651-2. PubMed ID: 22504383 [No Abstract] [Full Text] [Related]
9. [Pathology of intraductal papillary-mucinous tumor of the pancreas]. Nobukawa B; Suda K; Yamasaki S; Takase M; Fukumura Y; Shiono S Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):439-42. PubMed ID: 12854489 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Sato N; Fukushima N; Maitra A; Iacobuzio-Donahue CA; van Heek NT; Cameron JL; Yeo CJ; Hruban RH; Goggins M Am J Pathol; 2004 Mar; 164(3):903-14. PubMed ID: 14982844 [TBL] [Abstract][Full Text] [Related]
11. Pathologic aspects of intraductal papillary-mucinous neoplasm and pancreatic intraepithelial neoplasia--their associations with carcinogenesis. Furukawa T Nihon Shokakibyo Gakkai Zasshi; 2007 Sep; 104(9):1329-37. PubMed ID: 17827903 [No Abstract] [Full Text] [Related]
12. Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas? Wada K; Takada T; Yasuda H; Amano H; Yoshida M; Sugimoto M; Irie H J Gastrointest Surg; 2004; 8(3):289-96. PubMed ID: 15019925 [TBL] [Abstract][Full Text] [Related]
13. [Pancreatic tumor: progress in diagnosis and treatment. Topics: II. Intraductal papillary mucinous neoplasm of the pancreas (IPMN)/mucinous cystic neoplasm (MCN); 2. Pathology and pathobiology]. Furukawa T; Kuboki Y; Hatori T; Yamamoto M; Shibata N; Shiratori K Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):57-63. PubMed ID: 22413462 [No Abstract] [Full Text] [Related]
14. [Intraductal papillary-mucinous neoplasm of the pancreas]. Yamaguchi K; Watanabe M; Nakamura M; Konomi H; Tanaka M Nihon Rinsho; 2006 Jan; 64 Suppl 1():52-9. PubMed ID: 16457221 [No Abstract] [Full Text] [Related]
15. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome. Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555 [TBL] [Abstract][Full Text] [Related]
16. Pancreatobiliary-type intraductal papillary mucinous neoplasm of the pancreas may have 2 subtypes with distinct clinicopathologic and genetic features. Shimizu T; Akita M; Sofue K; Toyama H; Itoh T; Fukumoto T; Zen Y Hum Pathol; 2019 Sep; 91():26-35. PubMed ID: 31175918 [TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary mucinous carcinoma with co-mutations of Nagao M; Ueo T; Fukuda A; Ohana M BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 38011945 [No Abstract] [Full Text] [Related]
19. Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas. Sakamoto H; Kuboki Y; Hatori T; Yamamoto M; Sugiyama M; Shibata N; Shimizu K; Shiratori K; Furukawa T Mod Pathol; 2015 Feb; 28(2):261-7. PubMed ID: 25081753 [TBL] [Abstract][Full Text] [Related]
20. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas? Mandai K; Uno K; Yasuda K Pancreas; 2014 Aug; 43(6):917-21. PubMed ID: 24743378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]